Eli Lilly Awarded Summary Judgment in N.Y. Cymbalta Withdrawal Case

NEW YORK — A New York federal judge has awarded Eli Lilly & Co. summary judgment in a Cymbalta injury case, finding the drug maker adequately warned that abrupt discontinuation of the anti-depressant can cause withdrawal symptoms.

In a Nov. 6 order, Judge Robert W. Sweet of the U.S. District Court for the Southern District of New York concluded that the warning is adequate as a matter of law because it is "accurate, clear and consistent on its face" and "portrays with sufficient intensity the risk involved in taking the drug."

Jesse McDowell sued Lilly in June 2013, accusing …